Covid-19

GSK’s COVID-related sales close to $2 billion, profit boost to wane in 2022

By
1 Mins read
91
0
Share
Reading Time: < 1 minute

GSK racked up 1.4 billion pounds ($1.9 billion) in COVID-related sales in 2021, largely for antibody drug sotrovimab, Read More

91
0
Share
Related posts
Covid-19

Rise in Covid-19 hospital admissions as health chiefs warn of ‘winter threats’

By
1 Mins read
Reading Time: < 1 minute Covid-19 hospital admissions in England are continuing to rise, but remain at low levels, as health experts urged eligible people not to…
Covid-19

‘Beyond reasonable doubt’ Covid pandemic originated at Wuhan market stall

By
1 Mins read
Reading Time: < 1 minute It is beyond “reasonable doubt” that the Covid-19 pandemic originated in a Chinese animal market, a new scientific study has found.  Read More
Covid-19

New Covid variant XEC spreading rapidly and 'just getting started'

By
1 Mins read
Reading Time: < 1 minute A new Covid variant is spreading rapidly and experts say the strain is ‘just getting started’.  Read More
Subscribe to our Blog

Let's stay in touch. Subscribe to our blog and get our best content in your inbox. 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.